Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study

Abdullah Demirtas, Yunus Emre Yildirim, Mustafa Sofikerim, Esma Gunduz Kaya, Emre Can Akinsal, Sevket Tolga Tombul, Oguz Ekmekcioglu, Ibrahim Gulmez, Abdullah Demirtas, Yunus Emre Yildirim, Mustafa Sofikerim, Esma Gunduz Kaya, Emre Can Akinsal, Sevket Tolga Tombul, Oguz Ekmekcioglu, Ibrahim Gulmez

Abstract

This study aimed at determining the choice and administration duration of ideal antibiotic prophylaxis before percutaneous nephrolithotomy (PNL) operation, a treatment modality for nephrolithiasis. The study included 90 patients who had no internal problem, yet had a negative urine culture and underwent a PNL operation. We compared infection rates between ciprofloxacin and ceftriaxone groups and their subgroups. The results showed no statistical difference between ciprofloxacin and ceftriaxone groups in terms of systemic inflammatory response syndrome (SIRS) (CIP(P) = 0.306, CTX P = 0.334. As a result of this study no statistical difference was observed between ciprofloxacin and ceftriaxone in terms of SIRS. It seems, however, reasonable to choose ceftriaxone, considering antibiotic sensitivity of microorganisms and detection of three cases accepted as urosepsis in the ciprofloxacin group. As there is no difference between short, and long-term prophylactic use of these antibiotics, preference of short-term prophylaxis for patients with no risk of infection will be important to avoid inappropriate antibiotic usage.

References

    1. Menon M, Resnick MI. Urinary lithiasis: etiology, diagnosis, and medical management. In: Walsh PC, editor. Campbell's Urology. 8th edition. Vol. 4. Philadelphia, Pa, USA: Elsevier Saunders; 2002. pp. 3229–3230.
    1. Šahin A, Tekgul S, Erdem E, Ekici S, Hasçiçek M, Kendi S. Percutaneous nephrolithotomy in older children. Journal of Pediatric Surgery. 2000;35(9):1336–1338.
    1. Tiselius HG, Ackermann D, Alken P, et al. European Association of Urology Guidelines. 2007. Guidelines on urolitiasis; pp. 1–80.
    1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Critical Care Medicine. 2003;31(4):1250–1256.
    1. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. Journal of Urology. 1991;146(4):955–960.
    1. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. Journal of Urology. 2005;173(5):1610–1614.
    1. Streem SB. Stone extraction. In: Smith AD, Badlani GH, Bagley DH, et al., editors. Smith's Textbook of Endourology. St. Louis, Mo, USA: Quality Medical Publishing; 1996. p. p. 241.
    1. Charton M, Vallancien G, Veillon B, Brisset JM. Urinary tract infection in percutaneous surgery for renal calculi. Journal of Urology. 1986;135(1):15–17.
    1. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU International. 2006;98(5):1075–1079.
    1. Gault MH, Longerich LL, Crane G, et al. Bacteriology of urinary tract stones. Journal of Urology. 1995;153(4):1164–1170.
    1. Fowler JE., Jr. Bacteriology of branched renal calculi and accompanying urinary tract infection. Journal of Urology. 1984;131(2):213–215.
    1. McCartnaey AC, Clark J, Lewi HJ. Bacteriological study of renal calculi. European Journal of Clinical Microbiology & Infectious Diseases. 1985;4:553–555.
    1. Bratell S, Brorson JE, Grenabo L, Hedelin H, Pettersson S. The bacteriology of operated renal stones. European Urology. 1990;17(1):58–61.
    1. Hugosson J, Grenabo L, Hedelin H, Pettersson S, Seeberg S. Bacteriology of upper urinary tract stones. Journal of Urology. 1990;143(5):965–968.
    1. Dogan HS, Guliyev F, Çetinka YS, Sofikerim M, Ozden E, Sahin A. Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. International Urology and Nephrology. 2007;39(3):737–742.
    1. Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antibiotic prophylaxis in pecutaneous nephrolithhotomy: prospective study in 81 patients. Journal of Endourology. 2002;16:649–653.
    1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine. 2003;348(16):1546–1554.
    1. Clayman RV. Techniques in percutaneous removal of renal calculi. Mechanical extraction and electrohydraulic lithotripsy. Urology. 1984;23(5):11–19.
    1. Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA. Clinical implication of routine stone culture in percutaneous nephrolithotomy—a prospective study. Urology. 2006;67(1):26–29.
    1. Shigeta M, Hayashi M, Igawa M. A clinical study of upper urinary tract calculi treated with extracorporeal shock wave lithotripsy: association with bacteriuria before treatment. Urologia Internationalis. 1995;54(4):214–216.
    1. Cadeddu JA, Chen R, Bishoff J, et al. Clinical significance of fever after percutaneous nephrolithotomy. Urology. 1998;52(1):48–50.
    1. Turck M, Stamm W. Nosocomial infection of the urinary tract. The American Journal of Medicine. 1981;70(3):651–654.
    1. Bronsema DA, Adams JR, Pallares R, Wenzel RP. Secular trends in rates and etiology of nosocomial urinary tract infections at a University hospital. Journal of Urology. 1993;150(2):414–416.
    1. Farrell DJ, Morrissey I, de Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Journal of Infection. 2003;46(2):94–100.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe